{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:58:36Z","timestamp":1772755116164,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"crossref","award":["2023-JC-YB-807"],"award-info":[{"award-number":["2023-JC-YB-807"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"crossref","award":["2023-JC-YB-807"],"award-info":[{"award-number":["2023-JC-YB-807"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010246","name":"Postdoctoral Science Foundation of Jiangsu Province","doi-asserted-by":"crossref","award":["2021K524C"],"award-info":[{"award-number":["2021K524C"]}],"id":[{"id":"10.13039\/501100010246","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02179-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:38:15Z","timestamp":1751359095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of the pri-miR-34b\/c rs4938723 T\u2009&gt;\u2009C polymorphism with hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study"],"prefix":"10.1186","volume":"18","author":[{"given":"Wenli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1954-2892","authenticated-orcid":false,"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"5","key":"2179_CR1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/pbc.24215","volume":"59","author":"J Birch","year":"2012","unstructured":"Spector LG, Birch J. The epidemiology of hepatoblastoma. Pediatr Blood Cancer. 2012;59(5):776\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"2179_CR2","doi-asserted-by":"crossref","unstructured":"Spector LG, Puumala SE, Carozza SE et al. Cancer risk among children with very low birth weights. Pediatrics 2009:124(1):96\u2013104.","DOI":"10.1542\/peds.2008-3069"},{"issue":"3","key":"2179_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/cncr.35041","volume":"130","author":"GK Connolly","year":"2024","unstructured":"Connolly GK, Harris RD, Shumate C, et al. Pediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population-based assessment in seven million children. Cancer. 2024;130(3):467\u201375.","journal-title":"Cancer"},{"issue":"27","key":"2179_CR4","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1038\/sj.onc.1207499","volume":"23","author":"S Pakakasama","year":"2004","unstructured":"Pakakasama S, Chen TT, Frawley W, et al. CCND1 polymorphism and age of onset of hepatoblastoma. Oncogene. 2004;23(27):4789\u201392.","journal-title":"Oncogene"},{"issue":"3","key":"2179_CR5","first-page":"849","volume":"11","author":"Z Zhuo","year":"2021","unstructured":"Zhuo Z, Lin A, Zhang J, et al. Genetic variations in base excision repair pathway genes and risk of hepatoblastoma: a seven-center case-control study. Am J Cancer Res. 2021;11(3):849\u201357.","journal-title":"Am J Cancer Res"},{"issue":"9","key":"2179_CR6","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/ijc.33722","volume":"149","author":"Z Zhuo","year":"2021","unstructured":"Zhuo Z, Miao L, Hua W, et al. Genetic variations in nucleotide excision repair pathway genes and hepatoblastoma susceptibility. Int J Cancer. 2021;149(9):1649\u201358.","journal-title":"Int J Cancer"},{"key":"2179_CR7","doi-asserted-by":"crossref","unstructured":"Kahla JA, Siegel DA, Dai S et al. Incidence and 5-year survival of children and adolescents with hepatoblastoma in the united States. Pediatr Blood Cancer 2022:69(10):e29763.","DOI":"10.1002\/pbc.29763"},{"key":"2179_CR8","doi-asserted-by":"crossref","unstructured":"Meyers RL, Maibach R, Hiyama E et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic tumors International Collaboration. Lancet Oncol 2017:18(1):122\u201331.","DOI":"10.1016\/S1470-2045(16)30598-8"},{"issue":"1","key":"2179_CR9","first-page":"62","volume":"39","author":"J Feng","year":"2019","unstructured":"Feng J, Polychronidis G, Heger U, et al. Incidence trends and survival prediction of hepatoblastoma in children: a population-based study. Cancer Commun (Lond). 2019;39(1):62.","journal-title":"Cancer Commun (Lond)"},{"key":"2179_CR10","doi-asserted-by":"crossref","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004:116(2):281\u201397.","DOI":"10.1016\/S0092-8674(04)00045-5"},{"key":"2179_CR11","doi-asserted-by":"crossref","unstructured":"Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006:6(4):259\u201369.","DOI":"10.1038\/nrc1840"},{"key":"2179_CR12","doi-asserted-by":"crossref","unstructured":"Wojcicka A, de la Chapelle A, Jazdzewski K. MicroRNA-related sequence variations in human cancers. Hum Genet 2014:133(4):463\u20139.","DOI":"10.1007\/s00439-013-1397-x"},{"key":"2179_CR13","doi-asserted-by":"crossref","unstructured":"Ryan BM. MicroRNAs in Cancer susceptibility. Adv Cancer Res. 2017;135:151\u201371.","DOI":"10.1016\/bs.acr.2017.06.004"},{"issue":"1","key":"2179_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pharmthera.2012.08.016","volume":"137","author":"DW Salzman","year":"2013","unstructured":"Salzman DW, Weidhaas JB. SNPing cancer in the bud: MicroRNA and MicroRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer. Pharmacol Ther. 2013;137(1):55\u201363.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"2179_CR15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s10555-021-09973-3","volume":"40","author":"S Li","year":"2021","unstructured":"Li S, Wei X, He J, et al. The comprehensive landscape of miR-34a in cancer research. Cancer Metastasis Rev. 2021;40(3):925\u201348.","journal-title":"Cancer Metastasis Rev"},{"key":"2179_CR16","doi-asserted-by":"crossref","unstructured":"Zhang S, Qian J, Cao Q et al. A potentially functional polymorphism in the promoter region of miR-34b\/c is associated with renal cell cancer risk in a Chinese population. Mutagenesis 2014:29(2):149\u201354.","DOI":"10.1093\/mutage\/geu001"},{"issue":"3","key":"2179_CR17","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1159\/000481764","volume":"43","author":"K Yu","year":"2017","unstructured":"Yu K. The Rs4938723 polymorphism reduces expression of MicroRNA-34b and increases the risk of recurrence after endoscopic dissection in early gastric Cancer. Cell Physiol Biochem. 2017;43(3):1235\u201346.","journal-title":"Cell Physiol Biochem"},{"issue":"8","key":"2179_CR18","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1097\/HJH.0000000000002413","volume":"38","author":"G Wei","year":"2020","unstructured":"Wei G, Liao C, Jian C, et al. Evaluation of miR-34b\/c polymorphisms to the risk of ischemic stroke. J Hypertens. 2020;38(8):1481\u20137.","journal-title":"J Hypertens"},{"key":"2179_CR19","doi-asserted-by":"crossref","unstructured":"Zhang J, Huang X, Xiao J et al. Pri-miR-124 rs531564 and pri-miR-34b\/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations. PLoS ONE 2014:9(6):e100055.","DOI":"10.1371\/journal.pone.0100055"},{"issue":"11","key":"2179_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cancergen.2016.09.009","volume":"209","author":"M Hashemi","year":"2016","unstructured":"Hashemi M, Bahari G, Naderi M, et al. Pri-miR-34b\/c rs4938723 polymorphism is associated with the risk of childhood acute lymphoblastic leukemia. Cancer Genet. 2016;209(11):493\u20136.","journal-title":"Cancer Genet"},{"issue":"4","key":"2179_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/gtmb.2014.0287","volume":"19","author":"XM Pan","year":"2015","unstructured":"Pan XM, Sun RF, Li ZH, et al. Pri-miR-34b\/c rs4938723 polymorphism is associated with a decreased risk of gastric cancer. Genet Test Mol Biomarkers. 2015;19(4):198\u2013202.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"2","key":"2179_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3233\/CBM-160058","volume":"18","author":"M Hashemi","year":"2017","unstructured":"Hashemi M, Danesh H, Bizhani F, et al. Pri-miR-34b\/c rs4938723 polymorphism increased the risk of prostate cancer. Cancer Biomark. 2017;18(2):155\u20139.","journal-title":"Cancer Biomark"},{"issue":"6","key":"2179_CR23","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3109\/10428194.2015.1092528","volume":"57","author":"N Tong","year":"2016","unstructured":"Tong N, Chu H, Wang M, et al. Pri-miR-34b\/c rs4938723 polymorphism contributes to acute lymphoblastic leukemia susceptibility in Chinese children. Leuk Lymphoma. 2016;57(6):1436\u201341.","journal-title":"Leuk Lymphoma"},{"key":"2179_CR24","doi-asserted-by":"crossref","unstructured":"Xu B, Zhu Y, Tang Y et al. Rs4938723 polymorphism is associated with susceptibility to hepatocellular carcinoma risk and is a protective factor in leukemia, colorectal, and esophageal Cancer. Med Sci Monit 2018:24:7057\u201371.","DOI":"10.12659\/MSM.912534"},{"issue":"2","key":"2179_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/ijc.25342","volume":"128","author":"Y Xu","year":"2011","unstructured":"Xu Y, Liu L, Liu J, et al. A potentially functional polymorphism in the promoter region of miR-34b\/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer. 2011;128(2):412\u20137.","journal-title":"Int J Cancer"},{"issue":"3","key":"2179_CR26","doi-asserted-by":"publisher","first-page":"298","DOI":"10.21147\/j.issn.1000-9604.2024.03.06","volume":"36","author":"H Yin","year":"2024","unstructured":"Yin H, Wang X, Zhang S, et al. Nucleotide excision repair gene polymorphisms and hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study. Chin J Cancer Res. 2024;36(3):298\u2013305.","journal-title":"Chin J Cancer Res"},{"issue":"2","key":"2179_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00247-006-0361-5","volume":"37","author":"DJ Roebuck","year":"2007","unstructured":"Roebuck DJ, Aronson D, Clapuyt P, et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol. 2007;37(2):123\u201332. quiz 249\u2013\u2009150.","journal-title":"Pediatr Radiol"},{"issue":"7","key":"2179_CR28","doi-asserted-by":"publisher","first-page":"e3182","DOI":"10.1002\/jgm.3182","volume":"22","author":"P Liu","year":"2020","unstructured":"Liu P, Zhuo ZJ, Zhu J, et al. Association of TP53 rs1042522 C\u2009>\u2009G and miR-34b\/c rs4938723 T\u2009>\u2009C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study. J Gene Med. 2020;22(7):e3182.","journal-title":"J Gene Med"},{"issue":"8","key":"2179_CR29","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/jcmm.12836","volume":"20","author":"J He","year":"2016","unstructured":"He J, Wang F, Zhu J, et al. Association of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese population. J Cell Mol Med. 2016;20(8):1481\u201390.","journal-title":"J Cell Mol Med"},{"issue":"9","key":"2179_CR30","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s12519-022-00562-0","volume":"18","author":"YP Chen","year":"2022","unstructured":"Chen YP, Liao YX, Zhuo ZJ, et al. Association between genetic polymorphisms of base excision repair pathway and glioma susceptibility in Chinese children. World J Pediatr. 2022;18(9):632\u20135.","journal-title":"World J Pediatr"},{"issue":"2","key":"2179_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.21147\/j.issn.1000-9604.2023.02.05","volume":"35","author":"Q Guan","year":"2023","unstructured":"Guan Q, Lin H, Hua W, et al. Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression. Chin J Cancer Res. 2023;35(2):140\u201362.","journal-title":"Chin J Cancer Res"},{"issue":"2","key":"2179_CR32","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1002\/cai2.103","volume":"3","author":"Q Guan","year":"2024","unstructured":"Guan Q, Zhang X, Liu J, et al. ALKBH5 gene polymorphisms and risk of neuroblastoma in Chinese children from Jiangsu Province. Cancer Innov. 2024;3(2):e103.","journal-title":"Cancer Innov"},{"issue":"1","key":"2179_CR33","doi-asserted-by":"publisher","first-page":"e18006","DOI":"10.1111\/jcmm.18006","volume":"28","author":"L Ma","year":"2024","unstructured":"Ma L, Zhu J, Zhang J, et al. Identification of hepatoblastoma susceptibility loci in the TRMT6 gene from a seven-center case-control study. J Cell Mol Med. 2024;28(1):e18006.","journal-title":"J Cell Mol Med"},{"issue":"20","key":"2179_CR34","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.7150\/jca.33486","volume":"10","author":"Z Yan","year":"2019","unstructured":"Yan Z, Zhou Z, Li C, et al. Polymorphisms in MiRNA genes play roles in the initiation and development of cervical cancer. J Cancer. 2019;10(20):4747\u201353.","journal-title":"J Cancer"},{"issue":"5","key":"2179_CR35","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1002\/cam4.2073","volume":"8","author":"S Wu","year":"2019","unstructured":"Wu S, Shen W, Yang L, et al. Genetic variations in miR-125 family and the survival of non-small cell lung cancer in Chinese population. Cancer Med. 2019;8(5):2636\u201345.","journal-title":"Cancer Med"},{"issue":"5","key":"2179_CR36","doi-asserted-by":"publisher","first-page":"7734","DOI":"10.1002\/jcb.28047","volume":"120","author":"H Sadeghi","year":"2019","unstructured":"Sadeghi H, Nazemalhosseini-Mojarad E, Yaghoob-Taleghani M, et al. miR-30a promoter variation contributes to the increased risk of colorectal cancer in an Iranian population. J Cell Biochem. 2019;120(5):7734\u201340.","journal-title":"J Cell Biochem"},{"issue":"1","key":"2179_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12253-018-0412-x","volume":"26","author":"M Damodaran","year":"2020","unstructured":"Damodaran M, Paul SFD, Venkatesan V. Genetic polymorphisms in miR-146a, miR-196a2 and miR-125a genes and its association in prostate Cancer. Pathol Oncol Res. 2020;26(1):193\u2013200.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"2179_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12957-022-02724-w","volume":"20","author":"F Guo","year":"2022","unstructured":"Guo F, Li H, Wang L, et al. Rs6757 in microRNA-3976 binding site of CD147 confers risk of hepatocellular carcinoma in South Chinese population. World J Surg Oncol. 2022;20(1):260.","journal-title":"World J Surg Oncol"},{"key":"2179_CR39","doi-asserted-by":"publisher","first-page":"145834","DOI":"10.1016\/j.gene.2021.145834","volume":"800","author":"H Chen","year":"2021","unstructured":"Chen H, Duan F, Wang M, et al. Polymorphisms in METTL3 gene and hepatoblastoma risk in Chinese children: A seven-center case-control study. Gene. 2021;800:145834.","journal-title":"Gene"},{"issue":"12","key":"2179_CR40","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.7150\/jca.76255","volume":"13","author":"S He","year":"2022","unstructured":"He S, Zhu J, Xiao Z, et al. WDR4 gene polymorphisms increase hepatoblastoma susceptibility in girls. J Cancer. 2022;13(12):3342\u20137.","journal-title":"J Cancer"},{"key":"2179_CR41","doi-asserted-by":"crossref","unstructured":"Zhuo ZJ, Hua RX, Chen Z et al. WTAP gene variants confer hepatoblastoma susceptibility: A Seven-Center Case-Control study. Mol Ther Oncolytics 2020:18:118\u201325.","DOI":"10.1016\/j.omto.2020.06.007"},{"issue":"3","key":"2179_CR42","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s12033-024-01113-w","volume":"67","author":"S Chauhan","year":"2025","unstructured":"Chauhan S, Mathur R, Jha AK. The impact of MicroRNA SNPs on breast cancer: potential biomarkers for disease detection. Mol Biotechnol. 2025;67(3):845\u201361.","journal-title":"Mol Biotechnol"},{"issue":"1","key":"2179_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12094-023-03176-8","volume":"26","author":"Y Chhichholiya","year":"2024","unstructured":"Chhichholiya Y, Singh HV, Singh S, et al. Genetic variations in tumor-suppressor miRNA-encoding genes and their target genes: focus on breast cancer development and possible therapeutic strategies. Clin Transl Oncol. 2024;26(1):1\u201315.","journal-title":"Clin Transl Oncol"},{"key":"2179_CR44","doi-asserted-by":"crossref","unstructured":"Pan L, Shi Y, Zhang J et al. Association between single nucleotide polymorphisms of MiRNAs and gastric cancer: A scoping review. Genet Test Mol Biomarkers 2022:26(10):459\u201367.","DOI":"10.1089\/gtmb.2021.0258"},{"issue":"1","key":"2179_CR45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40659-021-00349-z","volume":"54","author":"T Arancibia","year":"2021","unstructured":"Arancibia T, Morales-Pison S, Maldonado E, et al. Association between single-nucleotide polymorphisms in MiRNA and breast cancer risk: an updated review. Biol Res. 2021;54(1):26.","journal-title":"Biol Res"},{"issue":"1","key":"2179_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/biomedicines10010156","volume":"10","author":"M Radanova","year":"2022","unstructured":"Radanova M, Levkova M, Mihaylova G, et al. Single nucleotide polymorphisms in MicroRNA genes and colorectal Cancer risk and prognosis. Biomedicines. 2022;10(1):156.","journal-title":"Biomedicines"},{"key":"2179_CR47","doi-asserted-by":"crossref","unstructured":"Xiao S, Lu L, Lin Z et al. LAYN serves as a prognostic biomarker and downregulates Tumor-Infiltrating CD8(+) T cell function in hepatocellular carcinoma. J Hepatocell Carcinoma 2024:11:1031\u201348.","DOI":"10.2147\/JHC.S464806"},{"issue":"8","key":"2179_CR48","doi-asserted-by":"publisher","first-page":"e1845","DOI":"10.1038\/cddis.2015.200","volume":"6","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Talmon G, Wang J. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer. Cell Death Dis. 2015;6(8):e1845.","journal-title":"Cell Death Dis"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02179-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:38:21Z","timestamp":1751359101000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-025-02179-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2179"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02179-4","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Children\u2019s Hospital of Nanjing Medical University (No: 202402008-1). The research was aligned with the ethical standards set forth by the Declaration of Helsinki. All participants\u2019 parents or legal guardians provided written informed consent prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}